Hexagon Capital Partners LLC Xenon Pharmaceuticals Inc. Transaction History

Hexagon Capital Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$34.16 - $39.73 $2,459 - $2,860	-72 Reduced 87.8%	10 $0
Q1 2023 Apr 24, 2023	SELL	$33.46 - $40.35 $903 - $1,089	-27 Reduced 24.77%	82 $2,000
Q4 2022 Jan 13, 2023	SELL	$33.06 - $39.43 $2,909 - $3,469	-88 Reduced 44.67%	109 $0
Q3 2022 Oct 17, 2022	BUY	$30.79 - $39.82 $6,065 - $7,844	197 New	197 $7,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Hexagon Capital Partners LLC with notifications on news.